NuVasive, Inc. announced the appointment of Siddhartha Kadia, Ph.D. to the Company's Board of Directors, effective February 1, 2021. Dr. Kadia has more than 20 years of experience in the medical technology industry with expertise in globally commercializing disruptive technology. He most recently served as president and CEO of EAG Laboratories.